- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02796417
The Efficacy of REHACOP Program in Schizophrenia (CSrehacopSZ)
June 6, 2016 updated by: University of Deusto
Implementation of REHACOP Cognitive Training Program in Schizophrenia
This study examined the efficacy of an integrative cognitive remediation program (REHACOP) to improve cognition, social cognition, clinical symptoms and functional outcome in patients with schizophrenia.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
111
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Biskai
-
Bilbao, Biskai, Spain, 48007
- University of Deusto
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnostic criteria for Schizophrenia according to American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
Exclusion Criteria:
- evidence of alcohol or drug abuse in the last 30 days
- previous history of significant lack of consciousness
- mental retardation
- relevant neurological or medical condition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Rehacop group
Cognitive rehabilitation
|
REHACOP group consists of 90-minute-long sessions 3 days per week.
Specifically, REHACOP group remediation consisted of: Attention unit (4 weeks) training sustained, selective, alternant and divided attention; Memory unit (3 weeks) focusing on visual and verbal learning, recall and recognizing memory; Language unit (3 weeks) including grammar, syntax, vocabulary, verbal fluency, verbal comprehension, abstract language; Executive functions unit (2 weeks) training cognitive planning, proverbs, analogies; and Social cognition unit (1 week) exercising theory of mind, social reasoning and moral dilemmas
|
|
Active Comparator: Control group
Occupational activities
|
Occupational group activities conducted included drawing, gardening, reading the daily news and constructing using different materials (such as paper or wood).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in functional competence after receiving cognitive remediation
Time Frame: 4 months
|
functional competence was measured with San Diego UCSD Performance-Based Skills Assessment- UPSA
|
4 months
|
|
Change in global functioning after receiving cognitive remediation
Time Frame: 4 months
|
global functioning measured with Global Assessment of Functioning (GAF)
|
4 months
|
|
change in verbal memory after receiving cognitive remediation
Time Frame: 4 months
|
Verbal memory performance was assessed with the Hopkins Verbal Learning Test-HVLT (Brandt and Benedict 2001)
|
4 months
|
|
change in processing speed after receiving cognitive remediation
Time Frame: 4 months
|
Processing speed was assessed with Digit Symbol subtest from Wechsler Adult Intelligence Scale-III (Wechsler 1997)
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in emotion perception after receiving cognitive remediation
Time Frame: 4 months
|
emotion perception was assessed with Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT)
|
4 months
|
|
change in clinical symptoms after receiving cognitive remediation
Time Frame: 4 months
|
Clinical symptoms was measured with Positive and Negative Syndrome Scale (PANSS)
|
4 months
|
|
change in social perception after receiving cognitive remediation
Time Frame: 4 months
|
Social perception was assessed with the Social Featuring Recognition Test (SFRT)
|
4 months
|
|
change in theory of mind after receiving cognitive remediation
Time Frame: 4 months
|
Theory of mind was assessed with Happe Strange Stories Test
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Natalia Ojeda, PhD, University of Deusto
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Pena J, Ibarretxe-Bilbao N, Sanchez P, Uriarte JJ, Elizagarate E, Gutierrez M, Ojeda N. Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia. J Psychiatr Res. 2018 Jun;101:21-27. doi: 10.1016/j.jpsychires.2018.03.002. Epub 2018 Mar 6.
- Pena J, Ibarretxe-Bilbao N, Sanchez P, Iriarte MB, Elizagarate E, Garay MA, Gutierrez M, Iribarren A, Ojeda N. Combining social cognitive treatment, cognitive remediation, and functional skills training in schizophrenia: a randomized controlled trial. NPJ Schizophr. 2016 Nov 9;2:16037. doi: 10.1038/npjschz.2016.37. eCollection 2016.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
May 13, 2016
First Submitted That Met QC Criteria
June 6, 2016
First Posted (Estimate)
June 10, 2016
Study Record Updates
Last Update Posted (Estimate)
June 10, 2016
Last Update Submitted That Met QC Criteria
June 6, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NSMC-003-UD
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
Bradley LegaRecruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Second Xiangya Hospital of Central South UniversityNot yet recruiting
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingSchizophrenia Disorder
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
Clinical Trials on REHACOP
-
University of DeustoCompletedMultiple SclerosisSpain
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
-
Universitat Autonoma de BarcelonaHospital Son Espases; Parc Sanitari Sant Joan de Déu; Andaluz Health Service; Hospital... and other collaboratorsRecruitingSchizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Schizoaffective Disorder | Delusional Disorder | Schizophreniform Disorders | Brief Psychotic DisorderSpain
-
University of DeustoCompleted